Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Banner Corp
BANR
$2.5B
| $3.7M | ﹤0.01% |
58,043
-20,421
| -26% | -$1.38M |
|
2127
Boyd Gaming
BYD
$6.05B
| $3.7M | ﹤0.01% |
56,220
-52,261
| -48% | -$3.83M |
|
|
AIV
2128
Aimco
AIV
$379M
| $3.68M | ﹤0.01% |
418,550
-158,716
| -27% | -$1.41M |
|
2129
Cohen & Steers
CNS
$4.4B
| $3.68M | ﹤0.01% |
45,885
-10,779
| -19% | -$920K |
|
2130
Dutch Bros
BROS
$8.93B
| $3.68M | ﹤0.01% |
59,579
-370,114
| -86% | -$24.4M |
|
2131
Mirion Technologies
MIR
$3.88B
| $3.68M | ﹤0.01% |
253,540
-99,782
| -28% | -$1.57M |
|
2132
XPeng
XPEV
$11.3B
| $3.67M | ﹤0.01% |
176,977
-33,543
| -16% | -$604K |
|
2133
iShares MSCI Mexico ETF
EWW
$1.87B
| $3.67M | ﹤0.01% |
71,953
-195,733
| -73% | -$9.88M |
|
2134
Mirum Pharmaceuticals
MIRM
$6.02B
| $3.66M | ﹤0.01% |
81,304
-170,660
| -68% | -$8.04M |
|
2135
First Merchants
FRME
$2.72B
| $3.65M | ﹤0.01% |
90,312
-31,657
| -26% | -$1.32M |
|
2136
Chesapeake Utilities
CPK
$3.26B
| $3.64M | ﹤0.01% |
28,370
-10,708
| -27% | -$1.33M |
|
|
AMED
2137
DELISTED
Amedisys
AMED
| $3.64M | ﹤0.01% |
39,306
-28,004
| -42% | -$2.58M |
|
2138
PUT
JD.com
JD
$39.6B
| $3.64M | ﹤0.01% |
88,500
+5,100
| +6% | +$205K |
|
|
TEM
2139
Tempus AI
TEM
$9.8B
| $3.64M | ﹤0.01% |
75,360
+40,403
| +116% | +$2.18M |
|
2140
Ocular Therapeutix
OCUL
$2.22B
| $3.63M | ﹤0.01% |
495,236
+163,994
| +50% | +$1.26M |
|
2141
AAR Corp
AIR
$5.77B
| $3.63M | ﹤0.01% |
64,777
-33,633
| -34% | -$2.23M |
|
2142
Huron Consulting
HURN
$2.47B
| $3.62M | ﹤0.01% |
25,232
-12,349
| -33% | -$1.66M |
|
2143
Victory Capital Holdings
VCTR
$7.27B
| $3.62M | ﹤0.01% |
62,534
-21,887
| -26% | -$1.39M |
|
2144
RLI Corp
RLI
$5.87B
| $3.61M | ﹤0.01% |
44,971
-19,601
| -30% | -$1.49M |
|
|
CON
2145
Concentra Group Holdings
CON
$4.48B
| $3.61M | ﹤0.01% |
166,474
-33,866
| -17% | -$745K |
|
2146
CALL
Antero Resources
AR
$11.3B
| $3.61M | ﹤0.01% |
89,300
| – | – |
|
2147
Valmont Industries
VMI
$9.5B
| $3.61M | ﹤0.01% |
12,636
-5,906
| -32% | -$1.93M |
|
2148
McGrath RentCorp
MGRC
$2.94B
| $3.6M | ﹤0.01% |
32,356
-12,128
| -27% | -$1.43M |
|
|
ITWO
2149
ProShares Russell 2000 High Income ETF
ITWO
$202M
| $3.6M | ﹤0.01% |
100,000
-100,000
| -50% | -$3.88M |
|
2150
Alamo Group
ALG
$1.99B
| $3.6M | ﹤0.01% |
20,217
-2,609
| -11% | -$479K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.